East African Collaborations in Practical Synthetic Biology Workshop
- Posted on 13 March
From the 15th-17th March 2017 SynbiCITE will attend a workshop to establish UK-East African collaborations in practical synthetic biology, taking place in Nairobi, Kenya. This will bring together researchers and policymakers from East Africa with academics and entrepreneurs from Imperial College London, University of Cambridge, University of Edinburgh and the John Innes Centre. The workshop will explore potential E. African application areas for practical synthetic biology including disease detection, agri-technology, environment, industrial processes as well as policy, IP and commercialisation opportunities.
The key objectives of this workshop are:
- Develop programmes on synthetic biology research and training
- Identify practical applications for synthetic biology solutions and biotechnologies
- Establish networks and collaborations on synthetic biology between Eastern African & UK researchers
- Facilitate communication, information exchange and education on synthetic biology
This is a unique and important opportunity for collaboration and we look forward to updating you on the insights to be generated from this meeting.
Share this article:
People also read
Synpromics raises £5.2m of new investment
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.
Touchlight welcomes Dr. Geoff Smith
Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.
Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition
Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol.